Decorin in the Tumor Microenvironment.

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• The tumor microenvironment significantly influences cancer progression through complex cell-matrix interactions.
• Decorin, a small leucine-rich proteoglycan, is found in various tissues and cancer stroma, playing roles in inflammation, fibrosis, and cancer.
• Initially known as a TGF-β inhibitor, decorin is recognized for its
• guardian from the matrix
• properties.

Purpose of the Study:

• To explore decorin's emerging role as a pan-RTK inhibitor in cancer therapy.
• To elucidate the mechanisms underlying decorin's antitumor activities.

Main Methods:

• Investigated decorin's interaction with various RTKs (e.g., EGFR, Met, IGF-IR, VEGFR2, PDGFR).
• Assessed decorin's effects on RTK signaling, internalization, and degradation.
• Evaluated decorin's impact on cell cycle, apoptosis, metastasis, angiogenesis, autophagy, and mitophagy.

Main Results:

• Decorin acts as a pan-RTK inhibitor, targeting multiple receptor tyrosine kinases.
• Decorin/RTK interactions lead to receptor internalization and degradation.
• Decorin induces cell cycle arrest, apoptosis, and inhibits metastasis and angiogenesis.
• Decorin promotes catabolic processes like endothelial cell autophagy and tumor cell mitophagy.

Conclusions:

• Decorin exhibits significant antitumor properties through diverse molecular mechanisms.
• Its ability to inhibit multiple RTKs and induce catabolic processes makes it a promising therapeutic candidate for RTK-dependent cancers.